Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different?

Crit Care. 2021 Dec 17;25(1):437. doi: 10.1186/s13054-021-03861-6.

Authors

Lies Langouche¹, Greet Van den Berghe¹, Jan Gunst²

Affiliations

¹ Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
² Clinical Department and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. [email protected].

No abstract available

Keywords: COVID-19; Diabetes; Hyperglycemia; Insulin.

Publication types

Letter

MeSH terms

COVID-19* / complications
COVID-19* / diagnosis
Critical Illness
Humans
Hyperglycemia*
Insulin Resistance*
SARS-CoV-2

Grants and funding